SARS-CoV-2 persistence and infectivity in COVID-19 corpses: a systematic review
- 24 August 2022
- journal article
- review article
- Published by Springer Nature in Forensic Science, Medicine and Pathology
- Vol. 19 (1) , 94-102
Abstract
The persistence and infectivity of SARS-CoV-2 in different postmortem COVID-19 specimens remain unclear despite numerous published studies. This information is essential to improve corpses management related to clinical biosafety and viral transmission in medical staff and the public community. We aim to understand SARS-CoV-2 persistence and infectivity in COVID-19 corpses. We conducted a systematic review according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) protocols. A systematic literature search was performed in PubMed, Science Direct Scopus, and Google Scholar databases using specific keywords. We critically reviewed the collected studies and selected the articles that met the criteria. We included 33 scientific papers that involved 491 COVID-19 corpses. The persistence rate and maximum postmortem interval (PMI) range of the SARS-CoV-2 findings were reported in the lungs (138/155, 89.0%; 4 months), followed by the vitreous humor (7/37, 18.9%; 3 months), nasopharynx/oropharynx (156/248, 62.9%; 41 days), abdominal organs (67/110, 60.9%; 17 days), skin (14/24, 58.3%; 17 days), brain (14/31, 45.2%; 17 days), bone marrow (2/2, 100%; 12 days), heart (31/69, 44.9%; 6 days), muscle tissues (9/83, 10.8%; 6 days), trachea (9/20, 45.0%; 5 days), and perioral tissues (21/24, 87.5%; 3.5 days). SARS-CoV-2 infectivity rates in viral culture studies were detected in the lungs (9/15, 60%), trachea (2/4, 50%), oropharynx (1/4, 25%), and perioral (1/4, 25%) at a maximum PMI range of 17 days. The SARS-CoV-2 persists in the human body months after death and should be infectious for weeks. This data should be helpful for postmortem COVID-19 management and viral transmission preventive strategy.Keywords
This publication has 51 references indexed in Scilit:
- Autopsies of COVID-19 deceased? Absolutely!Legal Medicine, 2020
- Pathological Findings in the Testes of COVID-19 Patients: Clinical ImplicationsEuropean Urology Focus, 2020
- Postmortem conjunctival and nasopharyngeal swabs in SARS‐CoV‐2 infected and uninfected patientsActa Ophthalmologica, 2020
- Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlationsInternational journal of legal medicine, 2020
- Postmortem Swabs in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: Report on 12 Complete Clinical Autopsy CasesArchives of Pathology & Laboratory Medicine, 2020
- Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 CasesAmerican Journal of Clinical Pathology, 2020
- Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wardsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- COVID-19American Journal of Forensic Medicine & Pathology, 2020
- Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agentsJournal of Hospital Infection, 2020
- 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trialCritical Care, 2020